What is Synapticure?
Headquartered in Chicago, Illinois, Synapticure is at the forefront of bringing personalized medical care online and directly to patients' homes. Founded by individuals with lived experience of ALS and in collaboration with leading ALS clinicians, the company is dedicated to revolutionizing the care landscape for all those affected by this progressive neurodegenerative disease. Synapticure's model focuses on providing comprehensive, patient-centric support, addressing the unique challenges faced by the ALS community.
How much funding has Synapticure raised?
Synapticure has raised a total of $31M across 2 funding rounds:
Angel/Seed
$6M
Series A
$25M
Angel/Seed (2022): $6M with participation from GV, Martin Ventures, David Hodgson, Lifeforce Capital Gp I, Joe Kraus, Gerald E. Bisbee, Jeff Huber, Adam Koppel, Y Combinator, Ben and Divya Silbermann, Rohan Seth, Byers Capital, and Ron Conway
Series A (2024): $25M led by GV, B Capital Group, CVS Health, and RA Capital Management
Key Investors in Synapticure
GV
GV is a venture capital firm specializing in enterprise solutions, life sciences, and frontier technology, providing financial backing to promising startups and growth-stage businesses globally.
B Capital Group
B Capital is a venture capital firm focused on empowering entrepreneurs by investing in early and late-stage companies within the Technology, Healthcare, and Climate sectors, with a global presence.
CVS Health
CVS Health aims to deliver high-quality, affordable healthcare through unmatched reach, focusing on superior and connected experiences to improve health and well-being.
What's next for Synapticure?
With the recent major strategic investment, Synapticure is poised for significant expansion and enhancement of its service offerings. This capital will likely fuel advancements in their technology platform, enabling broader reach and deeper integration of personalized care solutions. The company's focus on value-based care and patient outcomes, supported by strategic backers like GV and CVS Health, positions it for sustained growth and impact in the specialized field of ALS management and chronic disease care.
See full Synapticure company page
